Craft

Human Immunology Biosciences

Total Funding

$120 M

Human Immunology Biosciences Summary

Company Summary

Overview
Human Immunology Biosciences (HI-Bio) is a clinical-stage biotechnology company developing precision therapies for patients with immune-mediated diseases (IMDs). It provides therapy programs from early discovery through clinical development based on disease cellular drivers research. The company works in the fields of human genetics, immunophenotyping, therapeutic engineering, and data science.
Type
Private
Status
Active
Founded
2021
Website
https://hibio.com/
Cybersecurity rating
Sectors

Table of Contents

News

Footer menu